Skip to main content
An official website of the European UnionAn official EU website
European Commission logo

Drugs & drug processes

Designer proteins for new bio-tech applications

An EU-funded project has developed a technique to design and synthesise highly stable proteins. The approach enables proteins to be made from scratch, tailored to carry out specific tasks for advances in fields such as biomedicine and biotech - boosting Europe's competitiveness.

Add to pdf basket

Engineering vaccines to protect farm animals from infection

An EU-funded project is using synthetic biology techniques to design broad-spectra vaccines against mycoplasmas and viral infections in farm animals. By designing a growth medium without animal components and developing a platform to engineer new vaccines, the project will give the EU livestock industry a much-needed boost.

Add to pdf basket

Making vaccines immune to heat

Most vaccines need to be kept cool during transport and storage, but this can be hard to accomplish. EU-funded researchers keen to tackle this healthcare challenge have developed heat-tolerant and even needle-free formulations of an HIV-1 vaccine candidate. They expect their processes to work for many other vaccines as well.

Add to pdf basket

Faster, cheaper chemical reactions in miniature

Microfluidic bioreactors allow chemical reactions to take place on a very small scale, saving time, money and materials. An EU-funded project has developed microfluidic bioreactor technologies that could lead to a wide range of applications, including innovative medicines.

Add to pdf basket

A crystal-clear way to make crucial drugs more affordable

Monoclonal antibodies have emerged as a powerful weapon in the fight against a variety of diseases, including several types of cancer - but producing them remains a costly process. Crystallisation is the way forward, say EU-funded researchers working on an innovation that could make it easier, greener and far more affordable.

Add to pdf basket